Yubo International Biotech Limited Stock
Equities
YBGJ
US9883661004
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.845 USD | +8.33% | -9.63% | +181.67% |
Financials (USD)
Sales 2022 | 0.1 | Sales 2023 | 0.6 | Capitalization | 35.95M |
---|---|---|---|---|---|
Net income 2022 | -1M | Net income 2023 | -1M | EV / Sales 2022 | 116,560,264 x |
Net Debt 2022 | 772K | Net Debt 2023 | 386K | EV / Sales 2023 | 60,084,725 x |
P/E ratio 2022 |
-9.36
x | P/E ratio 2023 |
-30.1
x | Employees | 18 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 6.63% |
1 day | +8.33% | ||
1 week | -9.63% | ||
1 month | +69.37% | ||
3 months | +63.13% | ||
6 months | +63.98% | ||
Current year | +181.67% |
Managers | Title | Age | Since |
---|---|---|---|
Jun Wang
CEO | Chief Executive Officer | 57 | 18-12-31 |
Lina Liu
DFI | Director of Finance/CFO | 45 | 18-12-31 |
Wang Yang
BRD | Director/Board Member | 45 | 18-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Wang Yang
BRD | Director/Board Member | 45 | 18-12-31 |
Lina Liu
DFI | Director of Finance/CFO | 45 | 18-12-31 |
Zhi Hui Bai
BRD | Director/Board Member | 39 | 19-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-30 | 0.845 | +8.33% | 2,212 |
24-05-29 | 0.78 | -16.58% | 10,290 |
Delayed Quote OTC Markets, May 30, 2024 at 10:27 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+181.67% | 101M | |
+43.36% | 54.63B | |
-5.31% | 39.92B | |
+37.43% | 38.82B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+25.12% | 12.21B | |
+0.04% | 12.16B | |
+26.04% | 11.94B |
- Stock Market
- Equities
- YBGJ Stock